| Literature DB >> 35991437 |
Cheng Song1, Yunpeng Zhang2, Muhammad Aamir Manzoor3, Guohui Li1.
Abstract
Jasmonate (JA) signaling plays a pivotal role in plant stress responses and secondary metabolism. Many studies have demonstrated that JA effectively induce the expressions of alkaloid biosynthetic genes in various plants, which rendered to the accumulation of alkaloid to counteract stresses. Despite the multiple roles of JA in the regulation of plant growth and different stresses, less studied involved in the regulatory role of JA in Dendrobium officinale alkaloids. A strategy for the rapid identification of alkaloid and the intermediates of D. officinale was established based on a solid-phase extraction coupled with high-performance liquid chromatography tandem mass spectrometry method. By using SPE-LC-MS/MS method, the potential compounds were tentatively identified by aligning the accurate molecular weight with the METLIN and Dictionary of Natural Products databases. The chemical structures and main characteristic fragments of the potential compounds were further confirmed by retrieving the multistage mass spectra from the MassBank and METLIN databases. The Mass Frontier software was used to speculate the fragmentation pathway of the identified compounds. Seven alkaloids were separated and identified from D. officinale, which were mainly classified into five types (tropane alkaloids, tetrahydroisoquinoline alkaloids, quinolizidine alkaloids, piperidine alkaloids, and spermidine alkaloids). Besides the alkaloids, forty-nine chemical substances, including guanidines, nucleotides, dipeptides, sphingolipids and nitrogen-containing glucosides, were concurrently identified. These findings gives the composition of chemicals currently found in D. officinale, which could provide the scientific method for the identification of alkaloids in other Dendrobium plants.Entities:
Keywords: Dendrobium; alkaloid; hormone elicitor; liquid chromatography-mass spectrometry; solid-phase extraction (SPE)
Year: 2022 PMID: 35991437 PMCID: PMC9386266 DOI: 10.3389/fpls.2022.952051
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
FIGURE 1The fresh weight and alkaloid contents of Dendrobium officinale treated with 100 μM MeJA.
Identification of main chemical compounds from Dendrobium officinale.
| [M + H]+ | Formula | Error (mmu) | Fragment ions | Identification | |
| 2.64/3.19 | 118.0855 | C5H12O2N | −0.795 | MS2[118]:72 MS3[118→72]:55 | |
| 5.89/6.24 | 132.1010 | C6H14O2N | −0.905 | MS2[132]:86 MS3[132→86]:69;58 | |
| 3.81/7.73 | 136.0609 | C4H10O4N | −0.832 | MS2[136]:119;118;108;107;100;91;57 | 4-Hydroxy- |
| 5.00/6.42 | 139.0494 | C6H7O2N2 | −0.784 | MS2[139]: 121;111;95 | Urocanic acid |
| 2.81/3.02 | 142.1218 | C8H16ON | −0.841 | MS2[142]: 124;114;98;82;70;55 | Tropine or its isomers |
| 5.14/5.65 | 144.1011 | C7H14O2N | −0.835 | MS2[144]:126;86;84 | 2,3-Dihydroxynortropane or its isomers |
| 3.71 | 146.0914 | C5H12O2N3 | −0.973 | MS2[146]: 128;104;101;87;86;60 MS3[146→128]:111;86;84 | 4-Guanidinobutanoic acid |
| 1.21 | 147.1120 | C6H15O2N2 | −0.854 | MS2[147]:130; 129;84 MS3[147→130]:84 | |
| 4.06 | 152.0559 | C5H6ON5 | −0.806 | MS2[152]:136;135;134;124;110;109;90 | 2-Hydroxyadenine |
| 5.56 | 154.0967 | C7H12ON3 | −0.839 | MS2[154]:136;112;94;70 MS3[154→112]:95;94;84;70;69;67 | Cyclocimipronidine |
| 1.29 | 156.0759 | C6H10O2N3 | −0.873 | MS2[156]: 110; 95 MS3[156→110]: 93; 83 | |
| 6.42 | 160.1070 | C6H14O2N3 | −1.023 | MS2[160]:143;142;125;104;87;86;74 MS3[160→104]:87;86 | |
| 8.88 | 166.0853 | C9H12O2N | −1.005 | MS2[166]:120 MS3[166→120]:120;103;93;91 | |
| 1.36 | 175.1178 | C6H15O2N4 | −1.182 | MS2[175]: 158;140;130;116;112;70;60 | |
| 12.47 | 180.1007 | C10H14O2N | −1.225 | MS2[180]:163;120 MS3[180→120]:120;103;93 | β-Phenyl-γ-aminobutyric acid |
| 6.79 | 180.1008 | C10H14O2N | −1.075 | MS2[180]:163;145;137 MS3[180→163]:145;117 | |
| 7.00 | 182.0801 | C9H12O3N | −1.06 | MS2[182]:165;147;136 | |
| 1.60 | 189.1336 | C7H17O2N4 | −0.982 | MS2[189]:172;171;158;144;133;116;115;74;70 | |
| 7.34/7.65/8.73/9.43 | 203.1379 | C9H19O3N2 | −1.199 | MS2[203]:185;157;132;86 MS3[203→132]:86;69 | Alanyl-isoleucine or its isomers |
| 11.86 | 205.0960 | C11H13O2N2 | −1.144 | MS2[205]:188 MS3[205→188]:170;146;144 | |
| 4.09 | 217.1285 | C8H17O3N4 | −1.037 | MS2[217]:200;199;175;158;157;139;115;113;70 MS3[217→200]:183;158;157;139;115; 113;70 | |
| 8.04 | 217.1534 | C10H21O3N2 | −1.239 | MS2[217]:199;171;118;72 | Valyl-valine |
| 27.88 | 225.1945 | C13H25ON2 | −1.59 | MS2[225]:207;143;100;83; MS3[225→100]:83 | Anapheline |
| 26.46 | 230.2462 | C14H32ON | −1.641 | MS2 [230]:212;185; | 2-Amino-3-tetradecanol |
| 9.98/10.6/11.48 | 231.1690 | C11H23O3N2 | −1.309 | MS2[231]:213;185;132;72 MS3[231→72]:55 | Valyl-leucine or its isomers |
| 14.93 | 237.1219 | C12H17O3N2 | −1.469 | MS2[237]:219;205;180;177;175;148 | |
| 9.77 | 237.1219 | C12H17O3N2 | −1.469 | MS2[237]:219;120 MS3[237→120]: 120;103;93;91 | Carbetamide |
| 4.25 | 244.0913 | C9H14O5N3 | −1.487 | MS2[244]:112 MS3[244→112]:112;95 | Cytidine |
| 12.55/13.24/13.59/14.35 | 245.1844 | C12H25O3N2 | −1.599 | MS2[245]:227;199;132;86 | Leucyl-isoleucine or its isomers |
| 10.37 | 253.1280 | C11H17O3N4 | −1.557 | MS2[235]:236;235;225;208;193;192; | Prolyl-histidine |
| 11.41/12.73 | 265.1531 | C14H21O3N2 | −1.529 | MS2[265]:248;206;177;152;114;89 MS3[265→248]:177;145 | Phenylalanyl-valine or its isomers |
| 7.73 | 268.1025 | C10H14O4N5 | −1.58 | MS2[268]:136 MS3[268→136]:136;119;94;82 | Adenosine |
| 26.34 | 274.2720 | C16H36O2N | −2.026 | MS2[274]: 256;230;102;88; | 2-Amino-1,3-hexadecanediol |
| 14.93/15.67/16.20/16.48 | 279.1685 | C15H23O3N2 | −1.739 | MS2[279]:261;233;205;149;132;120; MS3[279→120]:103;93;91 | Isoleucyl-phenylalanine or its isomers |
| 8.73 | 282.1181 | C11H16O4N5 | −1.52 | MS2[282]:136 MS3[282→136]:136;119;94 | 1-Methyladenosine |
| 8.20 | 284.0973 | C10H14O5N5 | −1.685 | MS2[284]:152 MS3[284→152]:152;135;110;109 | Guanosine |
| 26.59 | 290.2670 | C16H36O3N | −1.97 | MS2[290]:272;242;122; MS3[290→242]:88 | 2-Amino-1,3,4-hexadecanetriol |
| 4.64 | 291.1286 | C10H19O6N4 | −1.311 | MS2[291]:175 | |
| 11.53/12.0/12.37/ | 295.1635 | C15H23O4N2 | −1.724 | MS2[295]:277;249;182;165;86; | Isoleucyl-tyrosine or its isomers |
| 11.66 | 297.1541 | C18H21O2N2 | −5.614 | MS2[297]:265;248 | Alamaridine |
| 7.52 | 314.0901 | C13H16O8N | 3.047 | MS2[314]:296;278;136;97 | 4- |
| 26.46 | 318.2982 | C18H40O3N | −2.111 | MS2[318]:300;256; MS3[318→256] 228;212;102;88 | 2-Amino-1,3,4-octadecanetriol |
| 6.87 | 332.1324 | C14H22O8N | −1.643 | MS2[332]: 314;233;170;152;136;108 | 5′- |
| 1.48 | 337.1701 | C12H25O7N4 | −1.706 | MS2[337]:319;301;283;260;257;217; | |
| 19.43 | 348.1784 | C19H26O5N | −2.139 | MS2 [348]: 207;175;142; 122; | 1,2-Dihydro- |
| 9.69 | 418.1685 | C18H28O10N | −2.282 | MS2[418]: 400;286;238;148 MS3[418→238]:220;208;202; 190; 174;172;164; 148;146;134;118;108;106 | Passicapsin |
| 16.78 | 438.2359 | C25H32O4N3 | −2.863 | MS2[438]:421;292;275;218;204;147; MS3[438→204]:147 | Meefarnine B |
| 9.16/9.51 | 454.1685 | C21H28O10N | −2.282 | MS2[454]:322;160 | |
| 16.05 | 454.2301 | C26H32NO6 | 7.686 | MS2[454]: 437;308;292;275;234;220;204;163;147 | Methyllagerine |
FIGURE 2The mass spectra of tropine and 2,3-dihydroxynortropane. (A) The MS2 spectrum of tropine, (B) the MS2 spectrum of 2,3-dihydroxynortropane or an isomer, and (C) the MS3 spectrum of 2,3-dihydroxynortropane or an isomer.
FIGURE 3The mass spectra of alamaridine and 1,2-dihydro-O-methyltazettine. (A) The MS2 spectrum of alamaridine, (B) the MS3 spectrum of alamaridine, (C) the MS2 spectrum of 1,2-dihydro-O-methyltazettine, and (D) the MS3 spectrum of 1,2-dihydro-O-methyltazettine.
FIGURE 4The mass spectra of methyllagerine N-oxide and meefarnine B. (A) The MS2 spectrum of methyllagerine N-oxide, (B) the MS2 spectrum of meefarnine B, and (C) the MS3 spectrum of meefarnine B.
FIGURE 5The putative fragmentation pathway of anapheline.
FIGURE 6The mass spectra of the guanidines. (A) The MS2 spectrum of 4-guanidinobutanoic acid, (B) the MS3 spectrum of 4-guanidinobutanoic acid, (C) the MS2 spectrum of cyclocimipronidine, (D) the MS3 spectrum of cyclocimipronidine, (E) the MS2 spectrum of N-tert-butyloxycarbonyl guanidine, and (F) the MS3 spectrum of N-tert-butyloxycarbonyl guanidine.